Daishin Balance No.6 Special Purpose Acquisition Co. Ltd Total Liabilities
Daishin Balance No.6 Special Purpose Acquisition Co. Ltd total liabilities. Based on the latest financial reports, Daishin Balance No.6 Special Purpose Acquisition Co. Ltd (307750) has total liabilities worth ₩79.37 Billion KRW (≈ $53.79 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Daishin Balance No.6 Special Purpose Acq asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Daishin Balance No.6 Special Purpose Acquisition Co. Ltd (2020–2024)
Total liabilities of Daishin Balance No.6 Special Purpose Acquisition Co. Ltd from 2020 to 2024. This chart illustrates how Daishin Balance No.6 Special Purpose Acquisition Co. Ltd's total liabilities have evolved over time, based on quarterly financial data.
Daishin Balance No.6 Special Purpose Acquisition Co. Ltd Competitors by Total Liabilities
The table below lists competitors of Daishin Balance No.6 Special Purpose Acquisition Co. Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
MediciNova Inc
NASDAQ:MNOV
|
USA | $3.61 Million |
|
ABITARE IN S.P.A.
F:1BN
|
Germany | €266.96 Million |
|
Simply Better Brands Corp
V:SBBC
|
Canada | CA$13.36 Million |
|
Hyundai Everdigm Corp
KQ:041440
|
Korea | ₩127.88 Billion |
|
DaChan Food (Asia) Limited
F:3DS
|
Germany | €1.29 Billion |
|
Omnisystem Co.Ltd
KQ:057540
|
Korea | ₩31.80 Billion |
|
Vortex Consolidated Bhd
KLSE:0060
|
Malaysia | RM74.10 Million |
|
Frontier Energy Ltd
AU:FHE
|
Australia | AU$5.64 Million |
Liability Composition Analysis (2020–2024)
This chart breaks down Daishin Balance No.6 Special Purpose Acquisition Co. Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see 307750 total assets.
Liquidity & Leverage Metrics
Daishin Balance No.6 Special Purpose Acquisition Co. Ltd Total Liabilities Ratios Explained
Daishin Balance No.6 Special Purpose Acquisition Co. Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.16 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.80 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.45 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Daishin Balance No.6 Special Purpose Acquisition Co. Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Daishin Balance No.6 Special Purpose Acquisition Co. Ltd (2020–2024)
The table below shows the annual total liabilities of Daishin Balance No.6 Special Purpose Acquisition Co. Ltd from 2020 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | ₩114.85 Billion ≈ $77.83 Million |
-10.02% |
| 2023-12-31 | ₩127.65 Billion ≈ $86.50 Million |
+23.00% |
| 2022-12-31 | ₩103.77 Billion ≈ $70.33 Million |
+335.32% |
| 2021-12-31 | ₩23.84 Billion ≈ $16.15 Million |
-6.78% |
| 2020-12-31 | ₩25.57 Billion ≈ $17.33 Million |
-- |
About Daishin Balance No.6 Special Purpose Acquisition Co. Ltd
KUKJEON PHARMACEUTICAL Co., Ltd operates as a chemical total solutions provider in South Korea. It provides various chemical-based products and services; and after-sales services, such as research and development, production, quality control, and DMF services. The company manufactures active pharmaceutical ingredients; and offers molecular design and technical support. It develops electronic mate… Read more